Biota secures US drug licence
Richard Gluyas
December 16, 2005[/B]
BIOTA Holdings has announced a licensing and collaboration agreement with US-based MedImmune to develop a product for the treatment and prevention of the respiratory infection RSV disease.
The deal supports Biota's persistent claim that it is more than a single-product company involved in a big litigation play.
The company is suing GlaxoSmithKline in the Victorian Supreme Court, alleging that GSK breached a licensing agreement to use its best endeavours to market Biota's breakthrough anti-flu drug Relenza.
The case began last year.
However, the legal exchange of documents between both parties, known as discovery, will continue well into next year.
[B]New chief executive Peter Cook announced the MedImmune deal yesterday, saying that it was rare for an Australian biotech company to have scored two global licensing deals. [/B]
[B]"We've hit the bullseye twice,"[/B] he said, as Biota shares gained 6c, or 4.2 per cent, to $1.47.
Biota has developed small-molecule compounds that are candidates for an orally taken drug.
If successfully developed, the products could expand the RSV market from high-risk paediatric patients to other susceptible groups such as older children, the elderly and people who have compromised immune systems.
[B]Under the terms of the agreement, Biota will receive an upfront payment of $US5 million ($6.6 million) and reimbursement of future research and development expenses on the collaborative RSV program.
The company could also receive payments of up to $US107.5 million if certain clinical and regulatory milestones are achieved, as well as a royalty on sales of a future licensed products. [/B]
The efficacy of the compounds has been demonstrated in animals, but human trials are probably two years away.
http://www.theaustralian.news.com.au/common/story_page/0,5744,17581755%255E643,00.html
- Forums
- ASX - General
- biota secures us drug licence
Biota secures US drug licenceRichard GluyasDecember 16,...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online